$TCRX 4 SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: MacBeath Gavin, Director Received 1,000,000 shares as a grant or award
02 Oct 2026	Form 4: Zdraveski Zoran, See Remarks Received 300,000 shares as a grant or award
22 May 2026	Form 4: Baker Bros. Advisors Lp, Director and 5 others Granted 134,000 Non- Qualified Stock Option (right to buy)
22 May 2026	Form 4: Woods Keith, Director Granted 67,000 Stock Option (Right to Buy)
22 May 2026	Form 4: Nicholson Garry A, Director Granted 67,000 Stock Option (Right to Buy)
22 May 2026	Form 4: Gruia Gabriela, Director Granted 67,000 Stock Option (Right to Buy)
22 May 2026	Form 4: Dorton Katina, Director Granted 67,000 Stock Option (Right to Buy)
22 May 2026	Form 4: Klencke Barbara, Director Granted 67,000 Stock Option (Right to Buy)
22 Jan 2026	Form 4: Amello Jason, Chief Financial Officer Granted 350,000 Stock Option (Right to Buy)
22 Jan 2026	Form 4: MacBeath Gavin, Director Granted 1,165,000 Stock Option (Right to Buy)
22 Jan 2026	Form 4: Dworak Leiden, See Remarks Granted 100,000 Stock Option (Right to Buy)
22 Jan 2026	Form 4: Louis Chrystal, Chief Medical Officer Granted 420,000 Stock Option (Right to Buy)
22 Jan 2026	Form 4: Zdraveski Zoran, See Remarks Granted 350,000 Stock Option (Right to Buy)
23 Dec 2025	Form 4: Lynx1 Capital Management Lp, 10% owner and 1 other Bought 80,069 shares ($72K) · Bought 75,500 shares ($68K) · Bought 6,232 shares ($5.6K)
02 Jul 2025	Form 4: Baker Bros. Advisors Lp, Director and 5 others Granted 134,000 Non- Qualified Stock Option (right to buy)
02 Jul 2025	Form 4: Klencke Barbara, Director Granted 67,000 Stock Option (Right to Buy)
02 Jul 2025	Form 4: Nicholson Garry A, Director Granted 67,000 Stock Option (Right to Buy)
02 Jul 2025	Form 4: Woods Keith, Director Granted 67,000 Stock Option (Right to Buy)
02 Jul 2025	Form 4: Dorton Katina, Director Granted 67,000 Stock Option (Right to Buy)
02 Jul 2025	Form 4: Gruia Gabriela, Director Granted 67,000 Stock Option (Right to Buy)

Comments